Did ZGEN recruit all new patients for the phase-2b portion of the trial? If not, how many patients were carried over from the phase-2a portion? If yes, why are the phase-2a and phase-2b portions of the trial not considered two distinct trials?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”